The fight over rbGH (recombinant bovine growth hormone) continues, even under new ownership.
After acquiring rbGH from Monsanto, Elanco (part of Eli Lilly) has stepped up efforts to convince milk processors and the wider food industry that milk from rbGH-injected cows is safe. Central to their new campaign is a paper, commissioned through PR company Porter-Novelli, from eight prominent experts and academics in medicine and dairy science
(Recombinant bovine somatotropin (rbST): a safety assessment).
The authors are Richard Raymond, former undersecretary for Food Safety at USDA, Connie Bales of Duke University Medical Centre, Dale Bauman of Cornell University, David Clemmons of the University of North Carolina, Ronald Kleinman of Harvard Medical school, Dante Lanna of the University of Sao Paolo, Stephen Nickerson of the University of Georgia, and Kristen Sejrsen of Aarhus University, Denmark. The new paper was not peer-reviewed but it was presented at the July 2009 joint annual meeting of the American Dairy Science Association, the Canadian Society of Animal Science and the American Society of Animal Science in Montreal, Canada. It argues strongly for the benefits and safety of rbGH milk and has been widely distributed by Elanco. According to
a rebuttal circulated by a number of consumer advocacy organisations, however, the paper misrepresents the position of various medical bodies
(1).
The paper claims, for instance, that the safety of rbGH is endorsed by the American Medical Association (AMA). Through their Campaign for Safe Food, Oregon Physicians for Social Responsibility (Oregon PSR), has pointed out that the AMA has no policy on rbGH and offers no such endorsement. Instead, they note the April 2008 AMA newsletter cites past president Ron Davis saying "Hospitals should......use milk produced without
recombinant bovine growth hormone".
Comment: For more information on a healing diet, see Primal Body, Primal Mind by Nora Gedgaudas.